Core Wealth Partners »

Alnylam Pharmaceuticals shares owned by Core Wealth Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Core Wealth Partners from 13F filings

Historical chart of Core Wealth Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Core Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Core Wealth Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $241k 800 301.03

More positions owned by Core Wealth Partners

Rockwell Automation (ROK)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
NVIDIA Corporation (NVDA)
Ametek (AME)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ishares Tr 0-3 Mth Treasury (SGOV)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
Spdr Series Trust St Str Blo 1 Etf (BIL)
JPMorgan Chase & Co. (JPM)
Costco Wholesale Corporation (COST)

View all positions for Core Wealth Partners

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Wellington Management Company
Dodge & Cox
American Century Companies
D. E. Shaw & Co
ClearBridge Advisors

View all funds holding Alnylam Pharmaceuticals